PLG and hyperinsulinemic hypoglycemia, familial, 4: PLG deficiency presents ongoing clinical challenges, including heterogeneous diagnostic criteria and a lack of targeted therapies, with fresh frozen plasma remaining the primary treatment option in China due to the absence of approved PLG-specific replacement therapies [19, 20].